Loading...
Moderna, Inc.
MRNA•NASDAQ
HealthcareBiotechnology
$27.46
$1.34(5.13%)
Moderna, Inc. (MRNA) Financial Performance & Statements
Review Moderna, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
-52.75%
↓ 52.75%
Operating Income Growth
6.94%
↑ 6.94%
Net Income Growth
24.46%
↑ 24.46%
Operating Cash Flow Growth
3.66%
↑ 3.66%
Operating Margin
-118.04%
↓ 118.04%
Gross Margin
52.55%
↑ 52.55%
Net Profit Margin
-106.27%
↓ 106.27%
ROE
-30.10%
↓ 30.10%
ROIC
-33.59%
↓ 33.59%
Moderna, Inc. (MRNA) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Moderna, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $966.00M | $1.85B | $241.00M | $167.00M |
| Cost of Revenue | $739.00M | $514.00M | $156.00M | $132.00M |
| Gross Profit | $227.00M | $1.34B | $85.00M | $35.00M |
| Gross Profit Ratio | $0.23 | $0.72 | $0.35 | $0.21 |
| R&D Expenses | $1.12B | $1.14B | $1.18B | $1.03B |
| SG&A Expenses | $351.00M | $281.00M | $268.00M | $274.00M |
| Operating Expenses | $1.47B | $1.41B | $1.45B | $1.30B |
| Total Costs & Expenses | $2.21B | $1.93B | $1.60B | $1.43B |
| Interest Income | $91.00M | $103.00M | $111.00M | $120.00M |
| Interest Expense | $6.00M | $6.00M | $6.00M | $6.00M |
| Depreciation & Amortization | $60.00M | $52.00M | $41.00M | $36.00M |
| EBITDA | -$1.12B | $79.00M | -$1.23B | -$1.12B |
| EBITDA Ratio | -$1.16 | $0.04 | -$5.11 | -$6.72 |
| Operating Income | -$1.25B | -$70.00M | -$1.36B | -$1.27B |
| Operating Income Ratio | -$1.29 | -$0.04 | -$5.66 | -$7.58 |
| Other Income/Expenses (Net) | $62.00M | $91.00M | $84.00M | $101.00M |
| Income Before Tax | -$1.18B | $21.00M | -$1.28B | -$1.17B |
| Income Before Tax Ratio | -$1.23 | $0.01 | -$5.31 | -$6.98 |
| Income Tax Expense | -$64.00M | $8.00M | $0.00 | $10.00M |
| Net Income | -$1.12B | $13.00M | -$1.28B | -$1.18B |
| Net Income Ratio | -$1.16 | $0.007 | -$5.31 | -$7.04 |
| EPS | -$2.91 | $0.03 | -$3.33 | -$3.08 |
| Diluted EPS | -$2.91 | $0.03 | -$3.33 | -$3.08 |
| Weighted Avg Shares Outstanding | $385.00M | $385.00M | $384.00M | $382.00M |
| Weighted Avg Shares Outstanding (Diluted) | $385.00M | $399.00M | $384.00M | $382.00M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan